Study Summary
Clinical Trial for the Efficacy and Safety of Sequential CD19 and CD22 CAR-T Therapy for Adult Patients With Newly Diagnosed Ph Chromosome Positive B-cell Acute Lymphoblastic Leukemia
Want to learn more about this trial?
Request More InfoInterventions
CAR-T cells targeting CD19 and CD22DRUG
Each subject receives sequential CD19 and CD22 CAR-T cells by intravenous infusion
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| The First Affiliated Hospital, College of Medicine, Zhejiang University | Hangzhou | Zhejiang | China |